News
This new article publication from Acta Pharmaceutica Sinica B, discusses how single-cell RNA sequencing reveals that Shen-Bai ...
Our group has developed four groups of strategies to enhance uniform targeting of the antigenically heterogenous cancer cells and to eliminate the “cold” tumor phenotypes: 1) Cell-based ...
These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...
Dendritic cells were also distinguished from other antigen-presenting cells, such as macrophages and B cells, on the basis of their potent capacity to stimulate T-cell responses, even when the other ...
What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier ...
Men around the world dealing with sexual impotence have been treated for years with the drug sildenafil, sold under brand ...
Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...
A dad who thought his headaches were caused by the stress of being a new father was diagnosed with an incurable brain tumour.
After Decades Without Progress in Glioblastoma, Diakonos Stirs up Interest in Dendritic Cell Vaccine
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
A recent Chinese study suggests that sildenafil, commonly known as Viagra, may have life-saving, cancer-fighting properties.
The vaccine uses the patient’s own dendritic cells to target tumor-specific neoantigens caused by disrupted RNA regulation.
Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results